MEC Plus – MyMedflix Member Portal

Skip to content

Live Events

Live Events

Live Events

Live Events

MEC Plus

Events

Speciality

Type of Media

Author / Speaker

Title

Search Entries:

«
1
…
8
9
10
11
12
…
100
»

HCC and Pancreatic Cancer: Novel Therapies after ASCO and ESMO 2024

HCC and Pancreatic Cancer: Novel Therapies after ASCO and ESMO 2024

Mitesh Borad, MD

What is New After ASCO and ESMO 2024 in Colon and Rectal Cancer Management?

What is New After ASCO and ESMO 2024 in Colon and Rectal Cancer Management?

Fernando de Zarraga, MD

New Endocrine and Targeted Agents for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

New Endocrine and Targeted Agents for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

Maria Theodoulou, MD

Post-Neoadjuvant Therapy after Residual Disease: How to Approach This Problem?

Post-Neoadjuvant Therapy after Residual Disease: How to Approach This Problem?

Lauren Carcas, MD

Progress in Neoadjuvant Therapy for Breast Cancer: Reviewing the Role of Immunotherapy, Endocrine and Anti-Her-2 Therapy

Progress in Neoadjuvant Therapy for Breast Cancer: Reviewing the Role of Immunotherapy, Endocrine and Anti-Her-2 Therapy

Gregory Vidal, MD

B-cell and T-cell NHL Challenges

B-cell and T-cell NHL Challenges

Eduardo Sotomayor, MD

Multiple Myeloma in 2024

Multiple Myeloma in 2024

Melissa Alsina, MD

Updates in CML and CLL

Updates in CML and CLL

Javier Pinilla-Ibarz, MD

Small-Cell Lung Cancer

Small-Cell Lung Cancer

Triparna Sen, PhD

Targeted Therapy in NSCLC

Targeted Therapy in NSCLC

Bruna Pellini, MD

Immunotherapy in NSCLC: Advanced Disease and Resistance

Immunotherapy in NSCLC: Advanced Disease and Resistance

George Simon, MD

Prostate Cancer: What is the Best Combination Therapy?

Prostate Cancer: What is the Best Combination Therapy?

Chandler H. Park, MD

Gynecologic Malignancies: New Therapeutic Developments

Gynecologic Malignancies: New Therapeutic Developments

Alexander B. Olawaiye, MD

Updates in Kidney and Bladder Cancers: Immunotherapy and Targeted Therapy

Updates in Kidney and Bladder Cancers: Immunotherapy and Targeted Therapy

Pedro Barata, MD

Latest Advances in Gastrointestinal Cancers

Latest Advances in Gastrointestinal Cancers

Edward Kim, MD, PhD

Therapeutic Advances in Gynecologic Oncology

Therapeutic Advances in Gynecologic Oncology

Rebecca Brooks, MD

New Therapeutic Directions in Lung Cancer

New Therapeutic Directions in Lung Cancer

Surbhi Singhal, MD

State of the Art in Genitourinary Cancers

State of the Art in Genitourinary Cancers

Nicholas Mitsiades, MD, PhD

Recent Advances in Breast Cancer

Recent Advances in Breast Cancer

Mili Arora, MD

ALL REVOLUTION: Improving Outcomes for ALL

ALL REVOLUTION: Improving Outcomes for ALL

Wendy Stock, MD

New Developments in Thrombosis Management in Cancer

New Developments in Thrombosis Management in Cancer

Anjlee Mahajan, MD

Recent Advances in Acute Leukemias

Recent Advances in Acute Leukemias

Brian A. Jonas, MD, PhD, FACP

Recent Updates in Multiple Myeloma

Recent Updates in Multiple Myeloma

Aaron Rosenberg, MD, MS

State of the Art in Non-Hodgkin Lymphoma

State of the Art in Non-Hodgkin Lymphoma

Joseph Tuscano, MD

Update on Sickle Cell Anemia and Hemoglobinopathies

Update on Sickle Cell Anemia and Hemoglobinopathies

Oyebimpe Adesina, MD, MS

Growing UP! Progress in Treatment of Young Adults with ALL

Growing UP! Progress in Treatment of Young Adults with ALL

Wendy Stock, MD

Empowering Research with Excelling and Expanding Pharmacy Services

Empowering Research with Excelling and Expanding Pharmacy Services

Vivian H. Nguyen, PharmD, BCPS

Establishment of a Biosimilar Economic Dashboard to Inform Organizational Strategy

Establishment of a Biosimilar Economic Dashboard to Inform Organizational Strategy

Halena Leah Marcelin, PharmD, MS, CPh, 340B ACE

Oncology Pharmacy Training; A Discussion with Kelley Carlstrom

Oncology Pharmacy Training; A Discussion with Kelley Carlstrom

Kelley D. Carlstrom, PharmD, BCOP

Two for the Price of One: Review of Bispecific Antibodies in Lymphoma and Myeloma

Two for the Price of One: Review of Bispecific Antibodies in Lymphoma and Myeloma

Claudia Martin Diaz, PharmD, BCPS, BCOP

Displaying 271 - 300 of 2,995

«
1
…
8
9
10
11
12
…
100
»

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok